en

Postdoc and PhD student position in cancer systems biology/immunology (# of pos: 2)

Postdoc and PhD student position in cancer systems biology/immunology (# of pos: 2)

Germany 31 Jan 2021
Heidelberg University Hospital

Heidelberg University Hospital

State University, Browse similar opportunities

OPPORTUNITY DETAILS

Total reward
0 $
State University
Area
Host Country
Deadline
31 Jan 2021
Study level
Opportunity type
PhD
Specialities
Opportunity funding
Full funding
Eligible Countries
This opportunity is destined for all countries
Eligible Region
All Regions

The biomedical campus of Heidelberg University, in close vicinity to other top research institutions, including the German Cancer Research Center (DKFZ) and the European Molecular Biology Laboratory (EMBL), belongs to the leading cancer research centers worldwide, which provides a supportive multidisciplinary working environment and offers state-of-the-art research facilities. The Department of Surgery with the European Pancreas Center at Heidelberg University Hospital isrecognized as one of the premier institutions for the diagnosis and treatment of pancreatic diseases, particularly for pancreatic cancer.

The research group of Susanne Roth MD, PhD at the Department of Surgery at Heidelberg University Hospital, Germany, offers a

Postdoc and PhD student position in cancer systems biology/immunology

Our newly established, international and enthusiastic research group is a member of the excellence initiative of the German Cancer Aid (Max-Eder-Program) that focuses on translational pancreatic/gastrointestinal cancer research and is integrated in the European Pancreas Center (https://www.europaeisches-pankreaszentrum.de/extrainfo/international-off... ) within an inspiringdynamic research environment. Our group studies how inflammatory responses influence gastrointestinal carcinogesis, especially in the pancreas. Specifically, we are interested in the detailed characterization of immune cell types and their interactions within the tumor microenvironment, understanding the molecular mechanisms that affect tumor cell growth, invasiveness and lead to therapy resistance in a translational research framework. To resolve heterogeneity in cell populations we apply single-cell technologies, combined with imaging and bioinformatic approaches. Our research findings are largely obtained from the direct study of patient-derived samples. To uncover the molecular mechanisms for tumour initiation and progression in vivo, we utilize genetically defined preclinical models. An improved understanding of the immune signaling pathways that contribute to tumorigenesis could enable the development of novel immunotherapeutic strategies against these devastating diseases. In addition, we develop therapy response prediction methods for individualized treatment strategies that could be immediately administered clinically.

The candidate will join a multidisciplinary team within a stimulating atmosphere with excellent scientific working conditions, access to state-of-the-art instrumentation at the Heidelberg University biomedical campus, networks with experienced scientists and further training opportunities. Starting ASAP we offer a postdoc and PhD student position for (initially) one year with the possibility of extension for 2-3 more years. Salary is paid according to the German public service scale based on candidates' background and experience (TV-L).


Other organizations


Choose your study destination


Choose the country you wish to travel to study for free, work or volunteer

Please find also


Featured tags


phd scholarships 2024 PhD program PhD Theses